COMP <GO>
MMED vs HAE // NET PROFIT MARGIN
MiniMed Group Inc. (NASDAQ) VS. Haemonetics Corporation (NYSE) • 15-METRIC TALLY: MMED 3
— HAE 8
▲ NET PROFIT MARGIN LEADER: HAE
LAST: $18.28 (-5.04%) • MKT CAP: $5.14B
net-margins
-10.70%
LAST: $119.65 (-0.12%) • MKT CAP: $5.44B
net-margins
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMED VS. HAE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMED | HAE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.20% | 59.00% | -4.80 | HAE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.90% | 8.40% | -12.30 | HAE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 32.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.75% | 4.78% | -12.53 | HAE | /fcf-yield <GO> |
| Operating Margin | -6.10% | 11.70% | -17.80 | HAE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -10.70% | 0.00% | -10.70 | HAE | /net-margins <GO> |
| Revenue Growth (YoY) | 14.30% | -2.00% | +16.30 | MMED | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.82 | 3.89 | +0.93 | MMED | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | HAE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.5 | 63.0 | -18.50 | HAE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.00 | +0.05 | MMED | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.14B | $5.44B | -$300.6M | HAE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMED REV | HAE REV | MMED GROSS % | HAE GROSS % | MMED FCF | HAE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.10B | $1.33B | 54.2% | 59.0% | -$420.0M | $260.4M |
| FY 2024 | $2.71B | $1.36B | 56.3% | 55.0% | -$53.0M | $142.4M |
| FY 2023 | $2.47B | $1.31B | — | — | -$70.1M | $122.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMED // BETA 1.05
HAE // BETA 1.00